Laurent Levy, founder and CEO of Nanobiotix, explains how a physics-based approach to drug delivery could complement existing therapeutic platforms by improving particle behavior in the body while avoiding added complexity.
Laurent Levy
Advertisement
Laurent Levy is CEO of Nanobiotix.
Articles by Laurent Levy
Nanobiotix CEO Discusses a Physics-Based Approach to Improving Therapeutic Delivery
Published: | Updated:
Laurent Levy, founder and CEO of Nanobiotix, discusses why physics-based therapeutics could complement traditional biology-driven drug development and explains how the company's NanoPrimer platform is designed to improve delivery of complex medicines.
Advertisement
Latest Updated Articles
Advertisement
Advertisement